AHN Cancer Institute at Forbes — Monroeville, Pennsylvania

AHN Cancer Institute at Forbes is a clinical research site located in Monroeville, Pennsylvania, United States 15146.

Crixeo Health Trust Score: 54/100 (POOR). This profile has not yet been claimed by the site owner.

AHN Cancer Institute at Forbes has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Sponsors: Daiichi Sankyo.

Sponsor Feasibility Report

Trust Score: 54/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for AHN Cancer Institute at Forbes?

AHN Cancer Institute at Forbes has a Crixeo Trust Score of 54/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has AHN Cancer Institute at Forbes conducted?

AHN Cancer Institute at Forbes has 1 clinical trials on record, with 1 currently active. Their work covers HER2-Positive Primary Breast Cancer, Residual Invasive Breast Cancer.

Is AHN Cancer Institute at Forbes accredited by Crixeo Health?

AHN Cancer Institute at Forbes has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about AHN Cancer Institute at Forbes?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.